AXA’s (CS) “Neutral” Rating Reiterated at DZ Bank

DZ Bank reiterated their neutral rating on shares of AXA (EPA:CS) in a research report report published on Wednesday.

Several other research firms have also weighed in on CS. UBS Group set a €24.50 ($29.17) price target on AXA and gave the company a neutral rating in a report on Monday, November 6th. JPMorgan Chase & Co. set a €28.80 ($34.29) price target on AXA and gave the company a buy rating in a report on Thursday, December 14th. Bank of America set a €29.00 ($34.52) price target on AXA and gave the company a buy rating in a report on Wednesday, December 13th. Deutsche Bank set a €28.50 ($33.93) price target on AXA and gave the company a buy rating in a report on Wednesday, November 22nd. Finally, HSBC set a €29.70 ($35.36) price target on AXA and gave the company a buy rating in a report on Thursday, December 7th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. AXA has an average rating of Buy and a consensus target price of €27.34 ($32.55).

Shares of AXA (CS) opened at €25.50 ($30.36) on Wednesday. AXA has a 52 week low of €21.81 ($25.96) and a 52 week high of €26.34 ($31.36). The firm has a market cap of $61,850.00 and a PE ratio of 10.85.

TRADEMARK VIOLATION NOTICE: This story was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://transcriptdaily.com/2018/01/06/axas-cs-neutral-rating-reiterated-at-dz-bank.html.

AXA Company Profile

AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply